RYTM insider trades & Congress trades
Rhythm Pharmaceuticals, Inc.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 20 open-market insider transactions in Rhythm Pharmaceuticals, Inc. (RYTM) (0 purchases with code P and 20 sales with code S), the most recent on September 14, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 20 sales by 6 ($28.8M).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Meeker David P | President and CEO | Sell | 8,698 | $103.43 | $900K | – |
| Sep 14, 2026 | Meeker David P | President and CEO | Sell | 6,439 | $101.75 | $655K | – |
| Sep 14, 2026 | Meeker David P | President and CEO | Sell | 1,817 | $104.55 | $190K | – |
| Sep 14, 2026 | Meeker David P | President and CEO | Sell | 30,746 | $102.35 | $3.15M | – |
| Sep 14, 2026 | Meeker David P | President and CEO | Sell | 2,300 | $105.19 | $242K | – |
| Aug 31, 2026 | Smith Hunter C | Chief Financial Officer | Sell | 23,072 | $104.59 | $2.41M | −0.1% |
| Aug 31, 2026 | Smith Hunter C | Chief Financial Officer | Sell | 11,514 | $105.37 | $1.21M | −0.1% |
| Aug 31, 2026 | Smith Hunter C | Chief Financial Officer | Sell | 28,188 | $106.20 | $2.99M | −0.1% |
| Aug 13, 2026 | Lee Jennifer Kayden | EVP, Head of North America | Sell | 75,834 | $117.38 | $8.90M | −0.2% |
| Aug 13, 2026 | Garfield Alastair | Chief Scientific Officer | Sell | 2,007 | $116.11 | $233K | −0.2% |
| Aug 13, 2026 | Garfield Alastair | Chief Scientific Officer | Sell | 1,556 | $117.08 | $182K | −0.2% |
| Aug 13, 2026 | Garfield Alastair | Chief Scientific Officer | Sell | 3,400 | $118.28 | $402K | −0.2% |
| Aug 13, 2026 | Garfield Alastair | Chief Scientific Officer | Sell | 800 | $119.17 | $95K | −0.2% |
| Aug 13, 2026 | Shulman Joseph | Chief Technical Officer | Sell | 5,079 | $119.75 | $608K | −0.2% |
| Aug 12, 2026 | Mazabraud Yann | EVP, Head of International | Sell | 2,300 | $111.80 | $257K | −0.2% |
| Aug 12, 2026 | Mazabraud Yann | EVP, Head of International | Sell | 1,000 | $112.86 | $113K | −0.2% |
| Aug 12, 2026 | Mazabraud Yann | EVP, Head of International | Sell | 3,605 | $114.70 | $413K | −0.2% |
| Aug 12, 2026 | Mazabraud Yann | EVP, Head of International | Sell | 14,568 | $115.43 | $1.68M | −0.2% |
| Aug 12, 2026 | Mazabraud Yann | EVP, Head of International | Sell | 18,208 | $116.49 | $2.12M | −0.2% |
| Aug 12, 2026 | Mazabraud Yann | EVP, Head of International | Sell | 17,319 | $117.47 | $2.03M | −0.2% |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.